Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Stratified, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Neurologic Function and Disability in Patients With Acute Ischemic Stroke Given Tissue Plasminogen Activator Plus YM872 or Tissue Plasminogen Activator Plus Placebo

NCT00044057 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00044057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00044057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Stratified, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Neurologic Function and Disability in Patients With Acute Ischemic Stroke Given Tissue Plasminogen Activator Plus YM872 or Tissue Plasminogen Activator Plus Placebo
Lead sponsor
Astellas Pharma Inc
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2000
Completion date
January 31, 2003
Enrollment
Not reported
Sites
118

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke